Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Rio

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 21, 2014
The corticotropin releasing hormone-1 (CRH1) receptor antagonist pexacerfont in alcohol dependence: a randomized controlled experimental medicine studyLaura E Kwako, Primavera A Spagnolo, Melanie L Schwandt, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 2, 2015
[Are extensive fields useful for radiotherapy of esophageal cancer?]G Peyraga, O Capitain, D Rousseau, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 22, 2013
[Adjuvant treatment of keloid scars: electrons or brachytherapy?]S Yossi, S Krhili, N Mesgouez-Nebout, et al.
British Journal of Cancer|October 14, 2010
Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancerT Conroy, Y Yataghène, P L Etienne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2013
Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trialE Deutsch, C Lemanski, J P Pignon, et al.
Journal of Neuroimmunology|October 25, 2003
A whole genome screen for association with multiple sclerosis in Portuguese patientsM Santos, J Pinto-Basto, M E Rio, et al.
European Urology Oncology|November 10, 2023
Penile Cancers Attributed to Human Papillomavirus Are Associated with Improved Survival for Node-positive Patients. Findings from a Norwegian Cohort Study Spanning 50 YearsChristian A Moen, Thea E Falkenthal, Tor K Thorkelsen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 11, 2011
Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesionsJ J Bonerandi, C Beauvillain, L Caquant, et al.
The Review of Scientific Instruments|January 1, 2022
Soft matter dynamics: A versatile microgravity platform to study dynamics in soft matterP Born, M Braibanti, L Cristofolini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 10, 2024
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trialT Conroy, F Castan, P-L Etienne, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 21, 2014
The corticotropin releasing hormone-1 (CRH1) receptor antagonist pexacerfont in alcohol dependence: a randomized controlled experimental medicine studyLaura E Kwako, Primavera A Spagnolo, Melanie L Schwandt, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 2, 2015
[Are extensive fields useful for radiotherapy of esophageal cancer?]G Peyraga, O Capitain, D Rousseau, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 22, 2013
[Adjuvant treatment of keloid scars: electrons or brachytherapy?]S Yossi, S Krhili, N Mesgouez-Nebout, et al.
British Journal of Cancer|October 14, 2010
Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancerT Conroy, Y Yataghène, P L Etienne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2013
Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trialE Deutsch, C Lemanski, J P Pignon, et al.
Journal of Neuroimmunology|October 25, 2003
A whole genome screen for association with multiple sclerosis in Portuguese patientsM Santos, J Pinto-Basto, M E Rio, et al.
European Urology Oncology|November 10, 2023
Penile Cancers Attributed to Human Papillomavirus Are Associated with Improved Survival for Node-positive Patients. Findings from a Norwegian Cohort Study Spanning 50 YearsChristian A Moen, Thea E Falkenthal, Tor K Thorkelsen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 11, 2011
Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesionsJ J Bonerandi, C Beauvillain, L Caquant, et al.
The Review of Scientific Instruments|January 1, 2022
Soft matter dynamics: A versatile microgravity platform to study dynamics in soft matterP Born, M Braibanti, L Cristofolini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 10, 2024
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trialT Conroy, F Castan, P-L Etienne, et al.
Pageof 9